The life expectancy of someone with Antiphospholipid Syndrome (APS) varies greatly depending on the severity of the condition and the presence of other comorbidities. Generally, life expectancy is not significantly reduced in those with APS alone, but it is usually shorter than the life expectancy of the general population.
Those with mild APS often have a normal life expectancy, but more severe cases can result in life-threatening complications. Those with APS might experience an increased risk of blood clots, stroke, and heart attack, all of which can reduce life expectancy. People with APS also have an increased risk of miscarriage and other pregnancy complications, which can also reduce life expectancy.
In addition, those with APS may have other comorbid conditions, such as lupus or rheumatoid arthritis, which can further complicate the prognosis. People with APS and other comorbidities may have a shorter life expectancy than those with APS alone.
Overall, the life expectancy of someone with APS depends on the severity of the condition and the presence of other comorbidities. Generally speaking, those with mild APS have a normal life expectancy, while those with more severe cases and other comorbidities may have a reduced life expectancy. With proper treatment and management of the condition, however, the life expectancy of someone with APS can be improved.